Bill Ackman calls Valeant (VRX) Bausch & Lomb� 'best in the business'
On the Valeant Pharma (NYSE: VRX) call ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
